Hager Investment Management Services LLC Invests $34,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 260 shares of the financial services provider’s stock, valued at approximately $34,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. James J. Burns & Company LLC lifted its position in shares of iShares Biotechnology ETF by 15.1% during the 4th quarter. James J. Burns & Company LLC now owns 2,361 shares of the financial services provider’s stock valued at $311,000 after acquiring an additional 310 shares during the period. Robbins Farley increased its stake in iShares Biotechnology ETF by 3.3% in the 4th quarter. Robbins Farley now owns 28,252 shares of the financial services provider’s stock valued at $3,735,000 after purchasing an additional 907 shares in the last quarter. Means Investment CO. Inc. raised its holdings in iShares Biotechnology ETF by 9.7% during the fourth quarter. Means Investment CO. Inc. now owns 10,320 shares of the financial services provider’s stock worth $1,364,000 after purchasing an additional 914 shares during the last quarter. HHM Wealth Advisors LLC boosted its position in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 150 shares in the last quarter. Finally, Valley National Advisers Inc. grew its holdings in iShares Biotechnology ETF by 10.4% in the fourth quarter. Valley National Advisers Inc. now owns 4,182 shares of the financial services provider’s stock valued at $552,000 after purchasing an additional 394 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $142.33 on Thursday. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The business has a fifty day simple moving average of $136.31 and a 200-day simple moving average of $141.47.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.